Investment Opportunity: Plan to Raise 50 Lakh INR for 15% equity | Contact: +91 9726359459

AI to solve cancer's most critical issues

Revolutionizing pathology with next generation technology

As longstanding leaders in AI, PathoxAI was among the first to apply the power of foundation models to cancer care and have since delivered numerous models that set new standards for size, scale and performance.

Digital Pathology

Transform glass slides into high-resolution digital images for AI-powered analysis and remote collaboration.

AI Diagnostics

Leverage advanced AI algorithms to detect and classify cancer cells with unprecedented accuracy.

Biomarker Analysis

Identify and quantify biomarkers to guide personalized treatment decisions and predict outcomes.

Workflow Efficiency

Streamline pathology workflows to reduce turnaround time and improve laboratory productivity.

Structured Reporting

Generate comprehensive, standardized reports with quantitative data and visual annotations.

Collaborative Platform

Enable seamless collaboration between pathologists, oncologists, and researchers.

Our Solutions

Clinical

Our AI-powered diagnostic solutions help pathologists make faster, more accurate diagnoses and enable personalized treatment decisions.

Life Sciences

Accelerate biomarker discovery and drug development with our advanced AI tools for tissue analysis and patient stratification.

Clinical Evidence

Our AI solutions are backed by robust clinical evidence and validation studies, ensuring reliability and performance in real-world clinical settings.

Explore Our Precision Medicine AI Portfolio

Gain access to best-in-class AI applications on the PathoxAI enterprise pathology platform.

Explore the broadest portfolio of research and diagnostic AI applications available in the market today. Applications from leading AI vendors across a wide range of tissue types are seamlessly deployed from PathoxAI directly into research and diagnostic workflows.

FDA Cleared
CE-IVD
Prostate Detect™
AI-powered detection and grading of prostate cancer in H&E-stained whole slide images.
diagnostic
oncology
prostate
H&E
Vendor: Ibex
RUO
Breast Metastasis Detector
Automated detection of metastatic breast cancer in lymph nodes with high sensitivity.
diagnostic
oncology
breast
lymph
H&E
Vendor: Mindpeak GmbH
RUO
Lung Nodule Classifier
Classification of lung nodules as benign or malignant with advanced deep learning.
diagnostic
oncology
lung
H&E
Vendor: DoMore Diagnostics
RUO
Melanoma AI
Detection and classification of melanoma and other skin lesions in histopathology slides.
diagnostic
oncology
skin
H&E
Vendor: Nucleai
RUO
Colon Polyp Analyzer
Automated detection and classification of colon polyps to identify precancerous lesions.
diagnostic
oncology
colon
H&E
Vendor: Stratipath
CE-IVD
HER2 Expression Analyzer
Quantitative analysis of HER2 expression in breast cancer for targeted therapy selection.
biomarker
oncology
breast
IHC
Vendor: Visiopharm
CE-IVD
PD-L1 Quantifier
Precise quantification of PD-L1 expression to guide immunotherapy decisions.
biomarker
oncology
multiple
IHC
Vendor: PathoxAI
RUO
Tumor Microenvironment Analyzer
Comprehensive analysis of the tumor microenvironment to predict treatment response.
research
oncology
multiple
H&E
IHC
Vendor: Nucleai
RUO
AI Report Generator
Automated generation of standardized pathology reports with key findings and measurements.
workflow
reporting
multiple
Other
Vendor: PathoxAI
RUO
Slide QC AI
Automated quality control of histology slides to identify artifacts and preparation issues.
workflow
quality
multiple
H&E
IHC
Other
Vendor: Visiopharm
CE-IVD
Liver Fibrosis Quantifier
Quantitative assessment of liver fibrosis to guide treatment decisions in chronic liver disease.
diagnostic
fibrosis
liver
Other
Vendor: Ibex
RUO
Kidney Pathology AI
Comprehensive analysis of kidney biopsies for diagnosis of various renal diseases.
diagnostic
kidney
H&E
Other
Vendor: DoMore Diagnostics

Preferred applications from our AI partners are available for purchase directly through PathoxAI.

Contact PathoxAI Today